Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-22

Clinical Trial Update: Safety and Efficacy of Esmketamine Versus Dexmedetomidine [Phase 4]

View source ↗

Summary

Clinical trial update comparing esmketamine to dexmedetomidine in phase 4 for obstructive sleep apnea syndrome (OSA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Esmketamine (esmketamine)

Snippet

Sponsor: Zhongnan Hospital | Conditions: Osa Syndrome | Phase 4 | Status: UNKNOWN